# EDGAR Filing Document

**Accession Number:** 0001577524
**File Stem:** 0001140361-23-004481
**Filing Date:** 2023-2
**Character Count:** 6748
**Document Hash:** 05a1a05bdd5669ab8dd1ae468a170256
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-23-004481.hdr.sgml**: 20230203

**ACCESSION NUMBER**: 0001140361-23-004481

**CONFORMED SUBMISSION TYPE**: DFAN14A

**PUBLIC DOCUMENT COUNT**: 7

**FILED AS OF DATE**: 20230203

**DATE AS OF CHANGE**: 20230203

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AMARIN CORP PLC\UK
- **CENTRAL INDEX KEY:** 0000897448
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DFAN14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-21392
- **FILM NUMBER:** 23587420

**BUSINESS ADDRESS:**
- **STREET 1:** SPACES SOUTH DOCKLANDS, BLOCK C
- **STREET 2:** 77 SIR JOHN ROGERSON'S QUAY
- **CITY:** DUBLIN 2
- **STATE:** L2
- **ZIP:** D02 VK60
- **BUSINESS PHONE:** 353 1 6699 020

**MAIL ADDRESS:**
- **STREET 1:** SPACES SOUTH DOCKLANDS, BLOCK C
- **STREET 2:** 77 SIR JOHN ROGERSON'S QUAY
- **CITY:** DUBLIN 2
- **STATE:** L2
- **ZIP:** D02 VK60

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AMARIN PHARMACEUTICALS PLC
- **DATE OF NAME CHANGE:** 20000201

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ETHICAL HOLDINGS PLC
- **DATE OF NAME CHANGE:** 19930322
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sarissa Capital Management LP
- **CENTRAL INDEX KEY:** 0001577524
- **IRS NUMBER:** 900924432
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DFAN14A

**BUSINESS ADDRESS:**
- **STREET 1:** 660 STEAMBOAT ROAD
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
- **BUSINESS PHONE:** 203-302-2330

**MAIL ADDRESS:**
- **STREET 1:** 660 STEAMBOAT ROAD
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830

#### UNITED STATES <br> SECURITIES AND EXCHANGE COMMISSION <br> Washington, D.C. 20549

### SCHEDULE 14A
**Proxy Statement Pursuant to Section 14(a) of the<br> Securities Exchange Act of 1934**<br>

Filed by the Registrant ☐

Filed by a party other than the Registrant ☒

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐ Soliciting Material under § 240.14a-12

#### Amarin Corporation plc
(Name of Registrant as Specified In Its Charter)

#### Sarissa Capital Catapult Fund LLC

#### Sarissa Capital Hawkeye Fund LP

#### ISP Fund LP

#### Sarissa Capital Offshore Master Fund LP

#### Sarissa Capital Master Fund II LP

#### Sarissa Capital Athena Fund Ltd

#### Atom Master Fund LP

#### Sarissa Capital Fund GP LP

#### Sarissa Capital Fund GP LLC

#### Sarissa Capital Offshore Fund GP LLC

#### Sarissa Capital Management GP LLC

#### Sarissa Capital Management LP

#### Alexander J. Denner, Ph.D.

#### Patrice Bonfiglio

#### Paul Cohen, M.D.<br> Mark DiPaolo<br> Keith L. Horn<br> Odysseas Kostas, M.D.

#### Louis Sterling III<br> Diane E. Sullivan

------

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒ No fee required <br> ☐ <br> Fee paid previously with preliminary materials <br> ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

&nbsp;&nbsp;&nbsp;&nbsp;

------

This filing contains a press release issued on February 3, 2023 by Sarissa Capital announcing that Sarissa Capital has launched a website at <u>www.FreeAmarin.com</u> in connection with its solicitation of shareholders of Amarin Corporation plc. This filing also contains materials posted by Sarissa Capital to <u>www.FreeAmarin.com</u>.

------

*SARISSA CAPITAL HIGHLIGHTS AMARIN'S DISREGARD FOR SHAREHOLDER INTERESTS AND URGES SHAREHOLDERS TO VOTE THE **BLUE** PROXY CARD FOR CHANGE AT AMARIN*

*Sarissa launches website <u>www.freeamarin.com</u> and posts presentation for shareholders*

*Sarissa urges shareholders to vote the **BLUE** proxy card by 11:59 PM EST on February 21, 2023*

*Do **NOT** vote Amarin's WHITE proxy card*

Greenwich, CT, February 3, 2023 – Sarissa Capital Management LP ("Sarissa") today made the following statement on Amarin Corporation plc (NASDAQ: AMRN):

Sarissa launches website for shareholders. For Sarissa's presentation, how to vote, and future communications, please visit Sarissa's website address below.

**Website:** <u>www.freeamarin.com</u>

**Presentation:** <u>https://freeamarin.com/wp-content/pdfs/presentation-slides-opt.pdf</u>

**How to vote:** <u>https://freeamarin.com/wp-content/pdfs/how-to-vote.pdf</u>

Vote the **BLUE** proxy card "**FOR**" all proposals. The General Meeting of Amarin shareholders is scheduled for February 28, 2023, BUT IN ORDER FOR YOUR VOTE TO BE VALID SARISSA MUST SUBMIT YOUR VOTE BEFORE 10 AM EST (NEW YORK TIME) ON FEBRUARY 22, 2023. **THEREFORE, WE ARE ASKING THAT ALL HOLDERS SUBMIT THEIR VOTE BY 11:59 PM EST (NEW YORK TIME) ON TUESDAY, FEBRUARY 21, 2023 (THE NIGHT BEFORE) OR THE EARLIEST TIME POSSIBLE.**

Shareholders should be receiving the **BLUE** proxy card next week. If you have any questions on how to vote, please contact

D.F. King & Co., Inc.

48 Wall Street

New York, New York 10005

**Shareholders call toll-free:** (800) 331-7024

**Banks and Brokers call:** (212) 269-5550

**By Email:** <u>AMRN@dfking.com</u>

#FreeAmarin

Contact: Jean Puong<br> Sarissa Capital Management LP<br> <u>info@sarissacap.com</u>

#### Additional Information
Sarissa Capital Management LP ("Sarissa Capital"), together with other participants, filed a definitive proxy statement and an accompanying blue proxy card with the SEC on January 31, 2023, in connection with the solicitation of shareholders of Amarin Corporation plc (the "Company") at the general meeting of the Company for the election of Sarissa Capital's slate of highly-qualified nominees (the "General Meeting"). Shareholders are advised to read the definitive proxy statement and other relevant documents related to the General Meeting as they contain important information.

The definitive proxy statement and other relevant documents are available at no charge on the SEC's website at www.sec.gov and at www.freeamarin.com. The definitive proxy statement and other relevant documents are also available at no charge by directing a request to Sarissa Capital's proxy solicitor, D.F. King & Co., Inc., 48 Wall Street, New York, New York 10005 (Shareholders can call toll-free: (800) 331-7024).

------

![](ny20006859x12_img1.jpg)

------

![](ny20006859x12_img2.jpg)

------

![](ny20006859x12_img3.jpg)

------

![](ny20006859x12_img4.jpg)

------

![](ny20006859x12_img5.jpg)

------

![](ny20006859x12_img6.jpg)

------